Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. slides stays in one workspace.
PCSA
$1.47
+8.89%
PCSA
· Processa Pharmaceuticals, Inc.
$1.47
+0.12 (+8.89%)
At close · Oct 9
Return incl. dividend (before tax)
Going-concern doubt
— cleared Aug 14, 2026
The latest filing states the doubt was alleviated.
“Following our acquisition of Vidya and closing of the related $200 million gross private placement (from which we received net proceeds of $183.3 million) on July 30, 2026, we believe our cash and cash equivalents will be sufficient to satisfy our cash requirements over the next 12 months and beyond. This represents a material change from what we reported in our 2025 Form 10-K that disclosed substantial doubt of our ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$3.77M
Shares
2.79M
Volume · Oct 9
2.97M
Avg daily vol (3M)
221.65K
All webcasts
Conference · 2026-09-11
Processa Pharmaceuticals, Inc. (PCSA) September 2026 Conference
Research coverage
1 live source
Open each available source without leaving this research workspace.
Research materials
Open the source you need; every reader stays inside this workspace.
Company presentation
Slides
15 pages · use arrow keys or swipe to navigate